aluates Reports

$ 0.0

Automative

Global Sickle Cell Treatment Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-20W9691

Global Sickle Cell Treatment Market Research Report 2022

BUY CHAPTERS

Global Sickle Cell Treatment Market Research Report 2025

Code: QYRE-Auto-20W9691

Report

March 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Global Blood Therapeutics Inc

Addmedica

Bristol-Myers Squibb Co

Baxter

Pfizer Inc

Eli Lilly and Co

GlycoMimetics

F.Hoffmann-La Roche

CRISPR Therapeutics

EMI Holding, Inc.

Medunik USA.Inc.

Bluebird Biotechnology

Sickle Cell Treatment Market Size

The global market for Sickle Cell Treatment was valued at US$ 242 million in the year 2024 and is projected to reach a revised size of US$ 352 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Sickle Cell Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Sickle Cell Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell Treatment.

The Sickle Cell Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sickle Cell Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sickle Cell Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sickle Cell Treatment Market Report

Report Metric	Details
Report Name	Sickle Cell Treatment Market
Accounted market size in year	US$ 242 million
Forecasted market size in 2031	US$ 352 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Blood Transfusion Bone Marrow Transplant Pharmacotherapy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, Global Blood Therapeutics Inc., EMI Holding, Inc., Addmedica Inc., Medunik USA.Inc., Bristol Myers Squibb Co., Baxter Inc., Bluebird Biotechnology, Pfizer Inc., Eli-Lilly and Co., Glycomimetics Inc., F.Hoffmann-La Roche, CRISPR Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sickle Cell Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sickle Cell Treatment Market growing?

Ans: The Sickle Cell Treatment Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Sickle Cell Treatment Market size in 2031?

Ans: The Sickle Cell Treatment Market size in 2031 will be US$ 352 million.

Who are the main players in the Sickle Cell Treatment Market report?

Ans: The main players in the Sickle Cell Treatment Market are Novartis AG, Global Blood Therapeutics Inc., EMI Holding, Inc., Addmedica Inc., Medunik USA.Inc., Bristol Myers Squibb Co., Baxter Inc., Bluebird Biotechnology, Pfizer Inc., Eli-Lilly and Co., Glycomimetics Inc., F.Hoffmann-La Roche, CRISPR Therapeutics

What are the Application segmentation covered in the Sickle Cell Treatment Market report?

Ans: The Applications covered in the Sickle Cell Treatment Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sickle Cell Treatment Market report?

Ans: The Types covered in the Sickle Cell Treatment Market report are Blood Transfusion, Bone Marrow Transplant, Pharmacotherapy

Recommended Reports

Blood Disorders

Therapy Devices

Treatment Drug Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Blood Transfusion

1.2.3 Bone Marrow Transplant

1.2.4 Pharmacotherapy

1.3 Market by Application

1.3.1 Global Sickle Cell Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sickle Cell Treatment Market Perspective (2020-2031)

2.2 Global Sickle Cell Treatment Growth Trends by Region

2.2.1 Global Sickle Cell Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Sickle Cell Treatment Historic Market Size by Region (2020-2025)

2.2.3 Sickle Cell Treatment Forecasted Market Size by Region (2026-2031)

2.3 Sickle Cell Treatment Market Dynamics

2.3.1 Sickle Cell Treatment Industry Trends

2.3.2 Sickle Cell Treatment Market Drivers

2.3.3 Sickle Cell Treatment Market Challenges

2.3.4 Sickle Cell Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sickle Cell Treatment Players by Revenue

3.1.1 Global Top Sickle Cell Treatment Players by Revenue (2020-2025)

3.1.2 Global Sickle Cell Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Sickle Cell Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Sickle Cell Treatment Revenue

3.4 Global Sickle Cell Treatment Market Concentration Ratio

3.4.1 Global Sickle Cell Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Treatment Revenue in 2024

3.5 Global Key Players of Sickle Cell Treatment Head office and Area Served

3.6 Global Key Players of Sickle Cell Treatment, Product and Application

3.7 Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Sickle Cell Treatment Breakdown Data by Type

4.1 Global Sickle Cell Treatment Historic Market Size by Type (2020-2025)

4.2 Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031)

5 Sickle Cell Treatment Breakdown Data by Application

5.1 Global Sickle Cell Treatment Historic Market Size by Application (2020-2025)

5.2 Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Sickle Cell Treatment Market Size (2020-2031)

6.2 North America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Sickle Cell Treatment Market Size by Country (2020-2025)

6.4 North America Sickle Cell Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sickle Cell Treatment Market Size (2020-2031)

7.2 Europe Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Sickle Cell Treatment Market Size by Country (2020-2025)

7.4 Europe Sickle Cell Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sickle Cell Treatment Market Size (2020-2031)

8.2 Asia-Pacific Sickle Cell Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sickle Cell Treatment Market Size (2020-2031)

9.2 Latin America Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Sickle Cell Treatment Market Size by Country (2020-2025)

9.4 Latin America Sickle Cell Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sickle Cell Treatment Market Size (2020-2031)

10.2 Middle East & Africa Sickle Cell Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Details

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG Sickle Cell Treatment Introduction

11.1.4 Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025)

11.1.5 Novartis AG Recent Development

11.2 Global Blood Therapeutics Inc.

11.2.1 Global Blood Therapeutics Inc. Company Details

11.2.2 Global Blood Therapeutics Inc. Business Overview

11.2.3 Global Blood Therapeutics Inc. Sickle Cell Treatment Introduction

11.2.4 Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.2.5 Global Blood Therapeutics Inc. Recent Development

11.3 EMI Holding, Inc.

11.3.1 EMI Holding, Inc. Company Details

11.3.2 EMI Holding, Inc. Business Overview

11.3.3 EMI Holding, Inc. Sickle Cell Treatment Introduction

11.3.4 EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.3.5 EMI Holding, Inc. Recent Development

11.4 Addmedica Inc.

11.4.1 Addmedica Inc. Company Details

11.4.2 Addmedica Inc. Business Overview

11.4.3 Addmedica Inc. Sickle Cell Treatment Introduction

11.4.4 Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.4.5 Addmedica Inc. Recent Development

11.5 Medunik USA.Inc.

11.5.1 Medunik USA.Inc. Company Details

11.5.2 Medunik USA.Inc. Business Overview

11.5.3 Medunik USA.Inc. Sickle Cell Treatment Introduction

11.5.4 Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.5.5 Medunik USA.Inc. Recent Development

11.6 Bristol Myers Squibb Co.

11.6.1 Bristol Myers Squibb Co. Company Details

11.6.2 Bristol Myers Squibb Co. Business Overview

11.6.3 Bristol Myers Squibb Co. Sickle Cell Treatment Introduction

11.6.4 Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025)

11.6.5 Bristol Myers Squibb Co. Recent Development

11.7 Baxter Inc.

11.7.1 Baxter Inc. Company Details

11.7.2 Baxter Inc. Business Overview

11.7.3 Baxter Inc. Sickle Cell Treatment Introduction

11.7.4 Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.7.5 Baxter Inc. Recent Development

11.8 Bluebird Biotechnology

11.8.1 Bluebird Biotechnology Company Details

11.8.2 Bluebird Biotechnology Business Overview

11.8.3 Bluebird Biotechnology Sickle Cell Treatment Introduction

11.8.4 Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025)

11.8.5 Bluebird Biotechnology Recent Development

11.9 Pfizer Inc.

11.9.1 Pfizer Inc. Company Details

11.9.2 Pfizer Inc. Business Overview

11.9.3 Pfizer Inc. Sickle Cell Treatment Introduction

11.9.4 Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.9.5 Pfizer Inc. Recent Development

11.10 Eli-Lilly and Co.

11.10.1 Eli-Lilly and Co. Company Details

11.10.2 Eli-Lilly and Co. Business Overview

11.10.3 Eli-Lilly and Co. Sickle Cell Treatment Introduction

11.10.4 Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025)

11.10.5 Eli-Lilly and Co. Recent Development

11.11 Glycomimetics Inc.

11.11.1 Glycomimetics Inc. Company Details

11.11.2 Glycomimetics Inc. Business Overview

11.11.3 Glycomimetics Inc. Sickle Cell Treatment Introduction

11.11.4 Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025)

11.11.5 Glycomimetics Inc. Recent Development

11.12 F.Hoffmann-La Roche

11.12.1 F.Hoffmann-La Roche Company Details

11.12.2 F.Hoffmann-La Roche Business Overview

11.12.3 F.Hoffmann-La Roche Sickle Cell Treatment Introduction

11.12.4 F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025)

11.12.5 F.Hoffmann-La Roche Recent Development

11.13 CRISPR Therapeutics

11.13.1 CRISPR Therapeutics Company Details

11.13.2 CRISPR Therapeutics Business Overview

11.13.3 CRISPR Therapeutics Sickle Cell Treatment Introduction

11.13.4 CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025)

11.13.5 CRISPR Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Global Blood Therapeutics Inc

Addmedica

Bristol-Myers Squibb Co

Baxter

Pfizer Inc

Eli Lilly and Co

GlycoMimetics

F.Hoffmann-La Roche

CRISPR Therapeutics

EMI Holding, Inc.

Medunik USA.Inc.

Bluebird Biotechnology

List of Tables

Table 1. Global Sickle Cell Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Blood Transfusion

Table 3. Key Players of Bone Marrow Transplant

Table 4. Key Players of Pharmacotherapy

Table 5. Global Sickle Cell Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Sickle Cell Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Sickle Cell Treatment Market Share by Region (2020-2025)

Table 9. Global Sickle Cell Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Sickle Cell Treatment Market Share by Region (2026-2031)

Table 11. Sickle Cell Treatment Market Trends

Table 12. Sickle Cell Treatment Market Drivers

Table 13. Sickle Cell Treatment Market Challenges

Table 14. Sickle Cell Treatment Market Restraints

Table 15. Global Sickle Cell Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Sickle Cell Treatment Market Share by Players (2020-2025)

Table 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)

Table 18. Ranking of Global Top Sickle Cell Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Sickle Cell Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Sickle Cell Treatment, Headquarters and Area Served

Table 21. Global Key Players of Sickle Cell Treatment, Product and Application

Table 22. Global Key Players of Sickle Cell Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Sickle Cell Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Sickle Cell Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Sickle Cell Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Sickle Cell Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Sickle Cell Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Sickle Cell Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Sickle Cell Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Sickle Cell Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Sickle Cell Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Sickle Cell Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Sickle Cell Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Sickle Cell Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Sickle Cell Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Sickle Cell Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Novartis AG Company Details

Table 48. Novartis AG Business Overview

Table 49. Novartis AG Sickle Cell Treatment Product

Table 50. Novartis AG Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 51. Novartis AG Recent Development

Table 52. Global Blood Therapeutics Inc. Company Details

Table 53. Global Blood Therapeutics Inc. Business Overview

Table 54. Global Blood Therapeutics Inc. Sickle Cell Treatment Product

Table 55. Global Blood Therapeutics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 56. Global Blood Therapeutics Inc. Recent Development

Table 57. EMI Holding, Inc. Company Details

Table 58. EMI Holding, Inc. Business Overview

Table 59. EMI Holding, Inc. Sickle Cell Treatment Product

Table 60. EMI Holding, Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 61. EMI Holding, Inc. Recent Development

Table 62. Addmedica Inc. Company Details

Table 63. Addmedica Inc. Business Overview

Table 64. Addmedica Inc. Sickle Cell Treatment Product

Table 65. Addmedica Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 66. Addmedica Inc. Recent Development

Table 67. Medunik USA.Inc. Company Details

Table 68. Medunik USA.Inc. Business Overview

Table 69. Medunik USA.Inc. Sickle Cell Treatment Product

Table 70. Medunik USA.Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 71. Medunik USA.Inc. Recent Development

Table 72. Bristol Myers Squibb Co. Company Details

Table 73. Bristol Myers Squibb Co. Business Overview

Table 74. Bristol Myers Squibb Co. Sickle Cell Treatment Product

Table 75. Bristol Myers Squibb Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 76. Bristol Myers Squibb Co. Recent Development

Table 77. Baxter Inc. Company Details

Table 78. Baxter Inc. Business Overview

Table 79. Baxter Inc. Sickle Cell Treatment Product

Table 80. Baxter Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 81. Baxter Inc. Recent Development

Table 82. Bluebird Biotechnology Company Details

Table 83. Bluebird Biotechnology Business Overview

Table 84. Bluebird Biotechnology Sickle Cell Treatment Product

Table 85. Bluebird Biotechnology Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 86. Bluebird Biotechnology Recent Development

Table 87. Pfizer Inc. Company Details

Table 88. Pfizer Inc. Business Overview

Table 89. Pfizer Inc. Sickle Cell Treatment Product

Table 90. Pfizer Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 91. Pfizer Inc. Recent Development

Table 92. Eli-Lilly and Co. Company Details

Table 93. Eli-Lilly and Co. Business Overview

Table 94. Eli-Lilly and Co. Sickle Cell Treatment Product

Table 95. Eli-Lilly and Co. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 96. Eli-Lilly and Co. Recent Development

Table 97. Glycomimetics Inc. Company Details

Table 98. Glycomimetics Inc. Business Overview

Table 99. Glycomimetics Inc. Sickle Cell Treatment Product

Table 100. Glycomimetics Inc. Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 101. Glycomimetics Inc. Recent Development

Table 102. F.Hoffmann-La Roche Company Details

Table 103. F.Hoffmann-La Roche Business Overview

Table 104. F.Hoffmann-La Roche Sickle Cell Treatment Product

Table 105. F.Hoffmann-La Roche Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 106. F.Hoffmann-La Roche Recent Development

Table 107. CRISPR Therapeutics Company Details

Table 108. CRISPR Therapeutics Business Overview

Table 109. CRISPR Therapeutics Sickle Cell Treatment Product

Table 110. CRISPR Therapeutics Revenue in Sickle Cell Treatment Business (2020-2025) & (US$ Million)

Table 111. CRISPR Therapeutics Recent Development

Table 112. Research Programs/Design for This Report

Table 113. Key Data Information from Secondary Sources

Table 114. Key Data Information from Primary Sources

Table 115. Authors List of This Report

List of Figures

Figure 1. Sickle Cell Treatment Picture

Figure 2. Global Sickle Cell Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sickle Cell Treatment Market Share by Type: 2024 VS 2031

Figure 4. Blood Transfusion Features

Figure 5. Bone Marrow Transplant Features

Figure 6. Pharmacotherapy Features

Figure 7. Global Sickle Cell Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Sickle Cell Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Sickle Cell Treatment Report Years Considered

Figure 13. Global Sickle Cell Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Sickle Cell Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Sickle Cell Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Sickle Cell Treatment Market Share by Players in 2024

Figure 17. Global Top Sickle Cell Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Treatment Revenue in 2024

Figure 19. North America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Sickle Cell Treatment Market Share by Country (2020-2031)

Figure 21. United States Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Sickle Cell Treatment Market Share by Country (2020-2031)

Figure 25. Germany Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Sickle Cell Treatment Market Share by Region (2020-2031)

Figure 33. China Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Sickle Cell Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Sickle Cell Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Sickle Cell Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Novartis AG Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 49. Global Blood Therapeutics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 50. EMI Holding, Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 51. Addmedica Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 52. Medunik USA.Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 53. Bristol Myers Squibb Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 54. Baxter Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 55. Bluebird Biotechnology Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 56. Pfizer Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 57. Eli-Lilly and Co. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 58. Glycomimetics Inc. Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 59. F.Hoffmann-La Roche Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 60. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Global Treatment Planning Software Market Research Report 2025

Hemoglobinopathy Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Malaria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Ant Killer Market Research Report 2024

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Therapy Drug Market Research Report 2025

Anti Hypertensive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cholesterol Reducer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs and Cosmetics Dyes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medicines for Alzheimer Disease Treatment Market Research Report 2025

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions